Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug duo aims to outsmart advanced lung cancer

NCT ID NCT03909334

Ongoing Disease control Sponsor: Xiuning Le Source: ClinicalTrials.gov ↗

Summary

This study is testing if adding a drug called ramucirumab to a standard targeted therapy (osimertinib) works better for controlling advanced lung cancer with a specific genetic change (EGFR mutation). It will involve about 160 adults who have not yet taken this type of targeted drug. The main goal is to see if the two-drug combination can delay cancer growth longer than the single drug alone.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Columbia University Irving Medical Center

    New York, New York, 10032, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, 98109, United States

  • Georgetown University

    Washington D.C., District of Columbia, 20057, United States

  • Indiana Univesity Melvin and Bren Simon Cancer Center

    Indianapolis, Indiana, 46202, United States

  • MD Anderson Cancer Center

    Houston, Texas, 77030, United States

  • Moffitt Cancer Center

    Tampa, Florida, 33612, United States

  • New York University Cancer Center

    New York, New York, 10016, United States

  • Northwestern University Feinberg School of Medicine

    Chicago, Illinois, 60611, United States

  • Providence Portland Medical Center

    Portland, Oregon, 97213, United States

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • Summit Medical Group, PA

    Berkeley Heights, New Jersey, 07922, United States

  • University of Virginia Health System

    Charlottesville, Virginia, 22908, United States

Conditions

Explore the condition pages connected to this study.

ADVANCED CANCER EGFR GENE MUTATION METASTATIC CANCER NON-SMALL-CELL LUNG CANCER